Fagron N.V. : On the road to achieve mid-term objectives supported by shareholders
>Trust from shareholders is coming back - In the past two months two of Fagron’s major investors reinforced their position in the company. Back in January, AOC Pharma SARL passed the 10% threshold (c.8m shares). Their first notification was in October 2022 when they acquired c.4m shares and their second was in December 2022 when they acquired additional shares adding up to c.6.4m. The last increase to c.8m of shares was done following an extensive due diligence of mo...Fagron supplies products, services to professionals and institutions in the healthcare sector in Europe, the U.S.A. and Brazil. Co.'s activities are subdivided into four divisions. Through Fagron, Co. offers products and concepts for pharmaceutical compounding. Through Arseus Dental, Co. supplies dental products and concepts to dentists and dental laboratories in Belgium, the Netherlands, France, Germany and Switzerland. Through Arseus Medical, Co. supplies medical and surgical products to specialists, elderly homes, homecare nurses and hospitals in Belgium and the Netherlands. Through Corilus, Co. supplies ICT total solutions for medical specialists in Belgium, the Netherlands and France.
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.